RT Journal Article
SR Electronic
T1 Extending preimplantation genetic diagnosis: medical and non-medical uses
JF Journal of Medical Ethics
JO J Med Ethics
FD BMJ Publishing Group Ltd and Institute of Medical Ethics
SP 213
OP 216
DO 10.1136/jme.29.4.213
VO 29
IS 4
A1 J A Robertson
YR 2003
UL http://jme.bmj.com/content/29/4/213.abstract
AB New uses of preimplantation genetic diagnosis (PGD) to screen embryos prior to transfer raise ethical, legal, and policy issues that deserve close attention. Extensions for medical purposes, such as to identify susceptibility genes, late onset disease, and human leukocyte antigen (HLA) matching, are usually ethically acceptable. Whether embryo screening for gender, perfect pitch, or other non-medical characteristics are also acceptable depends upon the parental needs served and the harm posed to embryos, children, and society. Speculations about potential future uses of PGD should not prevent otherwise acceptable current uses of PGD.